Temperature Controlled Freight:
Stop Pharma Loss in 2025 – Use This

13th August 2025

Temperature controlled freight is essential in 2025 for pharmaceutical logistics teams facing climate change, regulatory pressure, and rising global delays. With every shipment under scrutiny, protecting temperature controlled shipments from excursions is mission-critical. In this blog, discover how TLX Cargo’s passive insulation, PCM Fibre-Flex™, TLX8™, and TLX4™, helps you ship confidently across air, ocean, and road.

What Is Temperature Controlled Freight in Pharma Logistics?

Temperature controlled freight refers to the shipment of pharmaceuticals that must remain within a specific temperature band, typically 2–8 °C (cold chain) or 15–25 °C (controlled room temperature or CRT). These shipments include vaccines, insulin, biologics, blood components, and clinical trial materials.

A single temperature excursion, a deviation from the required range, can degrade drug efficacy, trigger regulatory violations, or even endanger patients. That’s why TLX Cargo designs passive thermal packaging using phase change materials (PCM), multi-layer reflective barriers, and flexible insulation to protect pharma freight through the most challenging legs of global distribution.

Introducing PCM Fibre-Flex™ – Built for Pharma Cold Chain

PCM Fibre-Flex™ is TLX Cargo’s most advanced passive cooling system. Designed for biologics, APIs, and clinical kits, it delivers reliable thermal performance during reefer unplug or tarmac delays, no dry ice or mechanical refrigeration required.

Benefits of PCM Fibre-Flex™:

Maintains 2–8 °C or 15–25 °C for 7–10 hours during power-loss events
Ultra-thin (~2 mm), flexible, and easy to wrap around pallets.
Foldable, reusable, shock-resistant and cost-saving

How it works:
PCM Fibre-Flex™ combines patented flexible insulation belts with phase change cooling to deliver targeted thermal protection. It’s ideal for intercontinental routes where reefer gaps, unplugged periods, or customs delays increase risk.

→ Learn more about PCM Fibre-Flex™

Meet TLX8™ and TLX4™:
Multi-Layer Insulation for Global Pharma

Not all temperature controlled freight requires bulky, powered systems. TLX8™ and TLX4™ are lightweight, high-performance insulation covers engineered to shield cargo from solar radiation, heat ingress, and ambient fluctuations, especially during exposure to uncontrolled environments, including thermal pallet covers that wrap pallets and containers for added protection.

TLX8™ – For Extreme Thermal Protection

Insulation using SOLARAP™ nanoporous material
Reflects up to 97% of solar radiation
Used in pallet covers, thermal pallet covers liners and thermal blankets
Suitable for ULDs, IBCs, pallets and boxes
Ideal for long-haul air freight or tropical climate zones

→ See TLX8™ product specs

TLX4™ – Lightweight Defence for CRT Shipments

Reflective insulation with a low-emissivity outer skin
Highly effective at blocking radiant heat and rapid ambient changes
GDP-compliant, waterproof, custom-cut for easy application
Designed for “last mile” delivery, airside-to-warehouse transfers and courier distribution

→ Explore TLX4™

Together, TLX8™ and TLX4™ deliver layered, validated protection that supports pharma cargo across multimodal, multi-stop lanes, especially during customs inspections, ramp waits, or handovers.

Why Pharma Cold Chain Is Under Threat in 2025

With global volatility rising, pharma cold chains are more exposed than ever:

a. Geopolitical Disruption
Trade wars, diplomatic tensions and customs bottlenecks are causing unexpected delays. Just 2–3 hours on a hot tarmac can cause an excursion, unless insulated protection is in place.
→ TLX8™ reduces thermal risk during dwell time in vulnerable airports.

b. Rising Regulatory Complexity
GDP, MHRA, EMA, FDA, and local Asia-Pacific rules all differ. Global compliance now demands full audit trails, validated packaging, and end-to-end temperature stability.
→ TLX Cargo’s covers meet GDP and ISO 9001 standards, backed by technical validation.

c. Cost Pressure & Airfreight Constraints
Refrigerated ULDs are expensive and limited in supply. With rising fuel costs and shrinking capacity, pharma shippers need lower-cost, scalable solutions.
→ PCM Fibre-Flex™ and TLX8™ deliver temperature stability, without mechanical cooling or dry ice.

How to Prevent Temperature Excursions in Pharma Freight

Every degree matters. Here’s how to build a fail-proof temperature controlled freight shipping plan:

a. Select the Right Insulation

Choose TLX8™ for long-haul, solar-intensive air freight; TLX4™ for last-mile CRT protection. custom-fit liners, pallet wraps and thermal cargo blankets provide complete thermal coverage.
→ Explore custom insulation options

b. Use Passive + Active Where Needed

PCM Fibre-Flex™, when used alongside TLX8™, provides 7–10 hours of thermal hold time during unplugged or tarmac events. This layered strategy gives intercontinental freight greater resilience during high-risk segments.

c. Choose the Right Partner

Not all packaging providers understand pharma. TLX Cargo partners directly with CROs, biotech firms, and 3PLs to engineer tailored solutions, validate lane performance, and support compliance.
→ Partner with TLX Cargo →

What’s Next for Temperature Controlled Freight?

a. Sustainable Innovation

Recyclable and reusable materials including thermal blanket pallet covers that can be returned and reused across shipments.
Reduced carbon impact vs. powered containers
Returnable insulation assets support circular supply chains

→ Protect product and planet, simultaneously.

b. Digital Integration

Compatible with data loggers and smart sensors
Supports audit-ready thermal reporting
Enables batch traceability and quality assurance

c. Custom Development

TLX works with pharma R&D and operations teams to co-create insulation systems that suit new products, biologics, and trial materials.

Whether you’re launching in LATAM or auditing routes into APAC, TLX has scalable solutions ready.

Who Should Use TLX Pharma Solutions?

Vaccine & Biotech firms shipping heat-sensitive biologics

CROs & Clinical Trial teams needing reliable last-mile protection

Cold Chain 3PLs building GDP-compliant packaging programs

Pharma Distributors with complex “hub-and-spoke” routes

API Manufacturers managing high-risk intercontinental logistics

Final Thoughts:
Protecting Pharma Cargo Starts with the Right System

In 2025, temperature controlled freight is no longer a value-add, it’s a mission-critical operation. Regulatory scrutiny, financial risk, and patient safety all depend on your ability to prevent temperature excursions across every mode, airport, and route.

TLX Cargo offers a better way: lightweight, validated, reusable passive solutions that outperform heavy active units in flexibility, cost, and sustainability.

Temperature Controlled Freight: Stop Pharma Loss in 2025 – Use This